DK154382A - Hidtil ukendte derivater af 2-piperazinopyrimidin,fremgangsmaader til deres fremstilling og deres anvendelse som laegemidlereller mellemprodukter til fremstilling af laegemidler - Google Patents

Hidtil ukendte derivater af 2-piperazinopyrimidin,fremgangsmaader til deres fremstilling og deres anvendelse som laegemidlereller mellemprodukter til fremstilling af laegemidler Download PDF

Info

Publication number
DK154382A
DK154382A DK154382A DK154382A DK154382A DK 154382 A DK154382 A DK 154382A DK 154382 A DK154382 A DK 154382A DK 154382 A DK154382 A DK 154382A DK 154382 A DK154382 A DK 154382A
Authority
DK
Denmark
Prior art keywords
preparation
medicinal
medicinal products
piperazinopyrimidine
procedures
Prior art date
Application number
DK154382A
Other languages
English (en)
Other versions
DK156722B (da
DK156722C (da
Inventor
F Audiau
C Gueremy
G L Fur
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of DK154382A publication Critical patent/DK154382A/da
Publication of DK156722B publication Critical patent/DK156722B/da
Application granted granted Critical
Publication of DK156722C publication Critical patent/DK156722C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK154382A 1981-04-07 1982-04-05 Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater DK156722C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8106924A FR2503162A1 (fr) 1981-04-07 1981-04-07 Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
FR8106924 1981-04-07

Publications (3)

Publication Number Publication Date
DK154382A true DK154382A (da) 1982-10-08
DK156722B DK156722B (da) 1989-09-25
DK156722C DK156722C (da) 1990-02-19

Family

ID=9257094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154382A DK156722C (da) 1981-04-07 1982-04-05 Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater

Country Status (21)

Country Link
US (1) US4535080A (da)
EP (1) EP0063509B1 (da)
JP (1) JPS57179167A (da)
AR (1) AR231442A1 (da)
AT (1) AT386199B (da)
AU (1) AU549748B2 (da)
CA (1) CA1175427A (da)
DE (1) DE3262374D1 (da)
DK (1) DK156722C (da)
ES (4) ES8306745A1 (da)
FI (1) FI78909C (da)
FR (1) FR2503162A1 (da)
GR (1) GR77331B (da)
HU (1) HU187673B (da)
IE (1) IE52872B1 (da)
IL (1) IL65422A (da)
MA (1) MA19438A1 (da)
MX (1) MX156087A (da)
NO (1) NO158739C (da)
PT (1) PT74712B (da)
ZA (1) ZA822344B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305524A1 (de) * 1983-02-18 1984-08-23 Celamerck Gmbh & Co Kg, 6507 Ingelheim Neue pyrimidinderivate
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS6143173A (ja) * 1984-08-06 1986-03-01 Mitsui Petrochem Ind Ltd 新規ピリミジン誘導体およびその製法
JP2561689B2 (ja) * 1986-02-24 1996-12-11 三井石油化学工業株式会社 神経疾患用治療薬
EP0257102B1 (en) * 1986-02-24 1997-11-19 Mitsui Petrochemical Industries, Ltd. Agents for treating neurophathy
WO1989000423A1 (en) 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
EP1984390A2 (en) * 2006-01-23 2008-10-29 Board of Trustees of Michigan State University Methods for breeding glyphosate resistant plants and compositions thereof
WO2010022121A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
PE20120325A1 (es) * 2009-05-19 2012-04-12 Dow Agrosciences Llc Aminopirimidinas sustituidas con arilo como agentes fungicidas
CN103204816B (zh) * 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 哌嗪基嘧啶类衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE485737A (da) * 1947-11-12
FR2257294B1 (da) * 1973-07-06 1977-07-01 Ugine Kuhlmann
NL129219C (da) * 1965-12-16
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
FR2173746B1 (da) * 1972-03-01 1975-04-25 Ugine Kuhlmann
FR2244520B1 (da) * 1973-07-06 1977-02-04 Ugine Kuhlmann
JPS578104B2 (da) * 1973-09-20 1982-02-15
GB1523274A (en) * 1974-08-05 1978-08-31 Ici Ltd Herbicidal compositions containing substituted pyrimidine
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
FR2311776A1 (fr) * 1975-05-23 1976-12-17 Sogeras Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides

Also Published As

Publication number Publication date
AU549748B2 (en) 1986-02-13
ES511224A0 (es) 1983-06-01
ES518975A0 (es) 1983-10-16
EP0063509A1 (fr) 1982-10-27
NO821159L (no) 1982-10-08
ES8400428A1 (es) 1983-10-16
DE3262374D1 (en) 1985-03-28
DK156722B (da) 1989-09-25
FR2503162A1 (fr) 1982-10-08
PT74712A (fr) 1982-05-01
GR77331B (da) 1984-09-11
ES8400429A1 (es) 1983-10-16
FR2503162B1 (da) 1983-11-25
IE820774L (en) 1982-10-07
AT386199B (de) 1988-07-11
EP0063509B1 (fr) 1985-02-20
MX156087A (es) 1988-07-04
DK156722C (da) 1990-02-19
CA1175427A (fr) 1984-10-02
MA19438A1 (fr) 1982-12-31
FI821203L (fi) 1982-10-08
FI821203A0 (fi) 1982-04-06
JPS57179167A (en) 1982-11-04
NO158739B (no) 1988-07-18
NO158739C (no) 1988-10-26
ES8400427A1 (es) 1983-10-16
US4535080A (en) 1985-08-13
IL65422A (en) 1985-04-30
AR231442A1 (es) 1984-11-30
ES518976A0 (es) 1983-10-16
ATA127682A (de) 1987-12-15
ES8306745A1 (es) 1983-06-01
ZA822344B (en) 1983-02-23
FI78909B (fi) 1989-06-30
FI78909C (fi) 1989-10-10
PT74712B (fr) 1983-10-25
ES518974A0 (es) 1983-10-16
HU187673B (en) 1986-02-28
IE52872B1 (en) 1988-03-30
AU8245082A (en) 1982-10-14
IL65422A0 (en) 1982-07-30

Similar Documents

Publication Publication Date Title
DK118791A (da) 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner, deres fremstilling og anvendelse som eller til fremstilling af laegemidler
DK195587A (da) Phenylpiperazinderivater og deres anvendelse til fremstilling af antiarrytmi-laegemidler
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK174079A (da) Substituerede 5,6-dimethylpyrrolo (2,3-d)pyrimidiner fremgangsmaade til deres fremsitlling og deres anvendelse som laegemidler
DK49283D0 (da) Pyrazoloxaziner, -thiaziner og - quinoliner, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler
DK189581A (da) Hidtil ukendte heparinestere der er anvendelige til fremstilling af laegemidler og fremgangsmaader til deres frmstilling
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK401180A (da) Acylerede triazolyl-gamma-fluorpinacolylderivater fremgangsmaader til deres fremstilling og deres anvendelse som fungicider
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK5379A (da) 1-aza-(2,2,2)-bicyclooctanderivater mellemprodukter hertil og fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK165985C (da) 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler
DK489378A (da) 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse
DK162220C (da) Tricykliske pyridazinderivater, som er agonister af cholinerge receptorer, fremgangsmaade til fremstilling af derivaterne, og laegemidler, hvori de er til stede
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK364682A (da) Substituerede azolylphenoxyderivater, deres fremstilling og anvendelse som fungicider
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DK437287D0 (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
DK506183A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK423284A (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK161187D0 (da) 5-phenyl-5h-indenooe1,2-daapyrimidin og derivater deraf samt fremgangsmaade til fremstilling af saadanneforbindelser.
DK511782A (da) Benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK688087A (da) Imidazolderivater, fremgangsmaade til fremstilling deraf og anvendelse deraf som antimycotiske midler

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed